Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy

NCT01720251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Rhinoconjunctivitis

Interventions

DRUG: placebo
DRUG: AllerT low dose
DRUG: AllerT full dose

Sponsor

Anergis